• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者酒精室间隔消融术与室间隔心肌切除术中心室心律失常的风险:一项关于室间隔减容治疗的荟萃分析

The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy.

作者信息

Tang Wei, Liu Menghui, Li Jie, Chang Rongxuan, Su Chen, Zhang Xiaoyu, Wang Lichun

机构信息

Department of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.

Department of Medicine College, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.

出版信息

Rev Cardiovasc Med. 2022 Nov 30;23(12):391. doi: 10.31083/j.rcm2312391. eCollection 2022 Dec.

DOI:10.31083/j.rcm2312391
PMID:39076650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270481/
Abstract

BACKGROUND

Alcohol septal ablation (ASA) has been more commonly applied in medical refractory hypertrophic obstructive cardiomyopathy (HOCM) compared with septal myectomy (SM), however its potential to create a proarrhythmic substrate is increased.

METHODS

A systematic search was performed in PubMed, EMBASE, Web of Science, and the Cochrane Library from inception to October 2020. Fixed or random effects models were used to estimate the risk ratios (RR) for ventricular arrhythmia events or other outcomes between the SM and ASA cohorts.

RESULTS

Twenty studies with 8025 patients were included. Pool analysis showed that the incidence of ventricular tachycardia (VT)/ventricular fibrillation (VF), which included appropriate implantable cardioverter defibrillator (ICD) intervention, was significantly higher in the ASA cohort than that in the SM cohort (ASA SM: 10% (345/3312) 5% (161/3227) (RR = 1.98, 95% CI (confidence interval), 1.65-2.37; 0.00001, = 0%). In both groups, more than 90% of VT/VF events occurred in the early phase (during the procedure, during hospitalization or within 30 days after the procedure) (ASA: 94.20%; SM: 94.41%). Further subgroup analysis also showed that the ASA group had a higher incidence of VT/VF in both the early phase (RR = 1.94, 95% CI, 1.61-2.33; 0.0001, = 0%) and the late phase (RR = 2.80, 95% CI, 1.00-7.89; = 0.05, = 33%). Furthermore, although the risks of sudden cardiac death (SCD) were similar between the ASA and SM groups, a higher incidence of sudden cardiac arrest (SCA), which included SCD and resuscitated SCA, was observed in the ASA group (RR = 2.30, 95% CI, 1.35-3.94; = 0.002, = 0%).

CONCLUSIONS

In patients with HOCM, those who received ASA showed a higher incidence of VF/VT and SCD combined with resuscitated SCA. The majority of VT/VF occurred in the early phase.

摘要

背景

与室间隔心肌切除术(SM)相比,酒精间隔消融术(ASA)在药物难治性肥厚性梗阻性心肌病(HOCM)中的应用更为普遍,但其产生致心律失常基质的可能性增加。

方法

从创刊至2020年10月在PubMed、EMBASE、科学网和Cochrane图书馆进行了系统检索。采用固定或随机效应模型估计SM组和ASA组之间室性心律失常事件或其他结局的风险比(RR)。

结果

纳入20项研究,共8025例患者。汇总分析显示,ASA组室性心动过速(VT)/室性颤动(VF)(包括适当的植入式心脏复律除颤器(ICD)干预)的发生率显著高于SM组(ASA组对SM组:10%(345/3312)对5%(161/3227)(RR = 1.98,95%置信区间(CI),1.65 - 2.37;P < 0.00001,I² = 0%)。在两组中,超过90%的VT/VF事件发生在早期阶段(手术期间、住院期间或手术后30天内)(ASA组:94.20%;SM组:94.41%)。进一步的亚组分析还显示,ASA组在早期阶段(RR = 1.94,95% CI,1.61 - 2.33;P < 0.0001,I² = 0%)和晚期阶段(RR = 2.80,95% CI,1.00 - 7.89;P = 0.05,I² = 33%)的VT/VF发生率均较高。此外,虽然ASA组和SM组的心源性猝死(SCD)风险相似,但ASA组观察到的心搏骤停(SCA)(包括SCD和复苏的SCA)发生率较高(RR = 2.30,95% CI,1.35 - 3.94;P = 0.002,I² = 0%)。

结论

在HOCM患者中,接受ASA治疗的患者VF/VT以及SCD合并复苏的SCA发生率较高。大多数VT/VF发生在早期阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/6e688c8807ec/2153-8174-23-12-391-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/ce386c756a49/2153-8174-23-12-391-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/92526eb5da6d/2153-8174-23-12-391-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/6e688c8807ec/2153-8174-23-12-391-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/ce386c756a49/2153-8174-23-12-391-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/92526eb5da6d/2153-8174-23-12-391-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/11270481/6e688c8807ec/2153-8174-23-12-391-g3.jpg

相似文献

1
The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy.肥厚型心肌病患者酒精室间隔消融术与室间隔心肌切除术中心室心律失常的风险:一项关于室间隔减容治疗的荟萃分析
Rev Cardiovasc Med. 2022 Nov 30;23(12):391. doi: 10.31083/j.rcm2312391. eCollection 2022 Dec.
2
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.酒精室间隔消融治疗梗阻性肥厚型心肌病后的室性心律失常
Am J Cardiol. 2009 Jul 1;104(1):128-32. doi: 10.1016/j.amjcard.2009.02.056. Epub 2009 May 4.
3
Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.肥厚型心肌病酒精性室间隔消融术后室性心律失常的连续节律监测
Heart. 2014 Dec;100(23):1865-70. doi: 10.1136/heartjnl-2014-305593. Epub 2014 Jul 29.
4
Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy.酒精间隔消融术还是间隔心肌切除术?肥厚型梗阻性心肌病间隔减容治疗的最新系统评价和荟萃分析
Front Cardiovasc Med. 2022 May 25;9:900469. doi: 10.3389/fcvm.2022.900469. eCollection 2022.
5
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.酒精间隔消融术与室间隔心肌切除术治疗梗阻性肥厚型心肌病:一项系统评价和荟萃分析
J Clin Med. 2020 Sep 23;9(10):3062. doi: 10.3390/jcm9103062.
6
A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者行间隔减除治疗后的长期疗效的系统评价和荟萃分析。
JACC Heart Fail. 2015 Nov;3(11):896-905. doi: 10.1016/j.jchf.2015.06.011. Epub 2015 Oct 7.
7
Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.酒精间隔消融术与肌切除术治疗症状性肥厚型梗阻性心肌病的系统评价和荟萃分析
Clin Cardiol. 2019 Jan;42(1):190-197. doi: 10.1002/clc.23113. Epub 2018 Nov 29.
8
Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?外科室间隔心肌切除术或酒精室间隔消融术:哪种方法能为肥厚型梗阻性心肌病患者带来更好的治疗效果?
Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):951-961. doi: 10.1093/icvts/ivx001.
9
Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.梗阻性肥厚型心肌病间隔缩减治疗的荟萃分析:治疗后总死亡率和心源性猝死的比较发生率。
Circ Cardiovasc Interv. 2010 Apr;3(2):97-104. doi: 10.1161/CIRCINTERVENTIONS.109.916676. Epub 2010 Mar 2.
10
Risk stratification for sudden cardiac death after septal myectomy.肥厚性梗阻型心肌病患者行室间隔心肌切除术后心脏性猝死的风险分层
J Cardiol Cases. 2011 Jan 13;3(2):e65-e67. doi: 10.1016/j.jccase.2010.12.002. eCollection 2011 Apr.

引用本文的文献

1
Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques.探索肥厚型心肌病风险分层的现状:从风险模型到有前景的技术。
J Cardiovasc Dev Dis. 2025 Mar 14;12(3):101. doi: 10.3390/jcdd12030101.

本文引用的文献

1
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
2
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.酒精间隔消融术与室间隔心肌切除术治疗梗阻性肥厚型心肌病:一项系统评价和荟萃分析
J Clin Med. 2020 Sep 23;9(10):3062. doi: 10.3390/jcm9103062.
3
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years.≤65 岁与>65 岁肥厚型心肌病患者行酒精室间隔消融术或室间隔心肌切除术的结局比较。
Am J Cardiol. 2020 Jul 15;127:128-134. doi: 10.1016/j.amjcard.2020.04.018. Epub 2020 Apr 22.
4
Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.心肌切除术与酒精室间隔消融术治疗肥厚型梗阻性心肌病。
Interact Cardiovasc Thorac Surg. 2020 Aug 1;31(2):158-165. doi: 10.1093/icvts/ivaa075.
5
Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.基于指南的间隔部心肌切除术治疗梗阻性肥厚型心肌病与良好的临床结局相关。
Circ Cardiovasc Interv. 2019 Jul;12(7):e007673. doi: 10.1161/CIRCINTERVENTIONS.118.007673. Epub 2019 Jul 12.
6
Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.酒精室间隔消融术治疗肥厚型梗阻性心肌病患者的生存情况。
J Am Coll Cardiol. 2018 Dec 18;72(24):3087-3094. doi: 10.1016/j.jacc.2018.09.064.
7
Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.酒精间隔消融术与肌切除术治疗症状性肥厚型梗阻性心肌病的系统评价和荟萃分析
Clin Cardiol. 2019 Jan;42(1):190-197. doi: 10.1002/clc.23113. Epub 2018 Nov 29.
8
Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.手术心肌切除术与酒精室间隔消融术治疗梗阻性肥厚型心肌病:倾向评分匹配队列研究。
J Thorac Cardiovasc Surg. 2019 Jan;157(1):306-315.e3. doi: 10.1016/j.jtcvs.2018.08.062. Epub 2018 Sep 5.
9
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病患者行介入性室间隔减容治疗的时机与结局。
Int J Cardiol. 2018 Dec 15;273:155-161. doi: 10.1016/j.ijcard.2018.09.004. Epub 2018 Sep 5.
10
Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.经皮腔内室间隔心肌消融术与改良 Morrow 室间隔切除术治疗肥厚型心肌病的临床效果比较。
Chin Med J (Engl). 2018 Mar 5;131(5):527-531. doi: 10.4103/0366-6999.226075.